NEX-20A

来那度胺皮下缓释注射剂

Report date: 2024/05/16 10:25:52
NME

Base Information

Drug NameNEX-20A
Drug Alias Name雷那度胺皮下缓释注射剂NEX-20A
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionInterleukin-6 inhibitorsCereblon inhibitorsCyclooxygenase-2 inhibitors +[4] 
TargetsCyclooxygenase-2Interleukin-6Tumor necrosis factor α +[4] 
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNanexa AB
China Registration ClassN/A

Develop Information

Active CompaniesNanexa AB
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG